Brain Neoplasms, Recurrent
1 clinical trials · Condition
◉ Watch Brain Neoplasms, Recurrent
| Record | Firm | Date |
|---|---|---|
| IDH1 Peptide Vaccine for Recurrent Grade II Glioma (NCT02193347) | Katy Peters, MD, PhD | 2016-01-28 |
Track Brain Neoplasms, Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.